Charles Nicolette - CSO and Vice President R&D, Argos Therapeutics Inc

As of April 25, 2018


Charles Nicolette Net Worth

  • Net worth is estimated to be at least $31.56K
  • Owns at least 399,990 units of Argos Therapeutics Inc stock
  • Sold an estimated value of $31.56K in the last 4 years at Argos Therapeutics Inc

Charles Nicolette Compensation at Argos Therapeutics Inc in 2016

  • Earned a $325,000 salary and a $121 bonus
  • Received a total compensation of $1,186,469

Charles Nicolette Trading

  • Largest purchase of shares was 5,000 units , worth over $32.25K on August 27, 2015
  • Largest sale of shares was 100,250 units , worth over $16.5K on January 12, 2018
  • In total has made about 11 transactions over 4 years
  • Usually trades in January, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Charles Nicolette Mailing Address

  • Mailing address is Argos Therapeutics, Inc. 4233 Technology Drive Durham NC 27704 NC

Argos Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Jeffrey D. Abbey 2016 $450,000 $356,500 $1,029,892 $26,477 $1,862,869
Jeffrey D. Abbey 2015 $450,000 $202,500 $714,502 $14,861 $1,381,863
Charles A Nicolette, Ph.D. 2016 $325,000 $121,875 $720,925 $18,669 $1,186,469
Charles A Nicolette, Ph.D. 2015 $325,000 $108,875 $446,564 $17,217 $897,656
Lee F. Allen, M.D., Ph.D. 2016 $407,292 $389,375 $1,016,592 $70,120 $1,883,379
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1105533/000117184317003980/def14a_070617.htm

Argos Therapeutics Inc Insider Trading

  • The most recent transaction was 64,329 units sold on January 12, 2018 by Lori R Harrelson worth over $10.59K
  • In the last 4 years, insiders at Argos Therapeutics Inc sold an estimated value of $79.34M and bought an estimated value of $13.75M
  • The most active traders are Jeffrey Abbey, Chief Executive Officer,  Pharmstandard Co Stock Joint,  and Sa International Pharmstandard
  • Insider trading is most common in January, with the busiest year in 2016

ARGOS THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1